Top Banner
Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment to meet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.
10

Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Aug 11, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

• •

Page 2: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

Page 3: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

Page 4: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

Page 5: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

Page 6: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

Page 8: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.

https://www.fda.gov/media/141477/download

Page 10: Medical Management for patients with confirmed COVID-19 · • See separate MIS-C guideline • Additional therapies specific to COVID-19 (see subsequent guideline pages for detail).

Disclaimer: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment tomeet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment.